Volume 28, Issue 5 pp. 349-353

Stability of intravesical epirubicin infusion: a sequential temperature study

G. J. Sewell PhD

G. J. Sewell PhD

Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, UK

Pharmacy Department, Derriford Hospital, Plymouth, UK

Search for more papers by this author
A. E. Rigby-Jones BSc

A. E. Rigby-Jones BSc

Pharmacy Department, Derriford Hospital, Plymouth, UK

Peninsula Medical School, Tamar Science Park, Plymouth, UK

Search for more papers by this author
M. J. Priston PhD

M. J. Priston PhD

Pharmacy Department, Derriford Hospital, Plymouth, UK

Peninsula Medical School, Tamar Science Park, Plymouth, UK

Search for more papers by this author
First published: 17 October 2003
Citations: 4
Professor Graham J. Sewell, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK. Tel.: 01225 826773; fax: 01225 826114;
e-mail: [email protected]

Summary

Objective: To investigate the stability of epirubicin bladder instillation, prepared from two different epirubicin formulations, under refrigerated storage, transportation and clinical use conditions.

Method: A sequential study design was used. Epirubicin instillation (1 mg/mL) in polypropylene syringes was sequential incubated for periods of 84 days at 8°C followed by 2 h at 25°C and 1 h at 37°C, the latter two temperatures replicating transport and intravesical conditions, respectively.

Results: The instillation was both chemically and physically stable under those incubation conditions. The formulation of epirubicin used to prepare the instillation infusions did not affect stability.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.